Jump to content
RemedySpot.com

Re: A useful review of AI (aspirin Intolerance) with relevance to asa desensitiz

Rate this topic


Recommended Posts

Guest guest
Posted

Wayne,This is indeed a

very good topic, but it looks like researchers do not have a clear picture

themselves. This is due to the fact that, when we look at aspirin intolerance

(AI), we are in fact speaking of a conglomerate of overlapping subsets. AERD is

a subset of AI, and it may overlap with, aspirin-induced urticaria, and, more

rarely, with other aspirin-induced conditions.

Then, neither is

AERD a homogeneous set itself ; it has several components that can be

classified according to area of exacerbation (upper airways alone or both upper

and lower airways), the severity of polyposis, the genetic origin(s) of the AE,

etc. This also reflects the observation that we are all different cases.

When we get to the

mechanism level, the most prevalent one is the Arachidonic Acid pathway, but a

lot of other reactions happen around at the same time, with IgE, lipoxins,

CysLT receptors, etc. Researchers have still a long way to go to elucidate how

all these reactions and mediators interact together, and it will be a tough job

because the order of prevalence of these reactions may vary from one subset to

the other.

Regarding the

IgE-mediated anaphylactic shock,

- Jenneck et al

write that : "However, some patients develop an anaphylactic

reaction with acute urticaria and angioedema or even

anaphylactic shock after the second exposition to NSAIDs or

aspirin, although it has been well tolerated during previous applications.

In these cases, the reactions are based on the development of drug specific IgE

antibodies against aspirin21 or NSAIDs, which explains the relatively low

rate of cross reactions to other NSAIDs observable in these

patients.22"

21 and 22 being :

21. Blanca M,

E, JJ, et al. Angioedema and IgE antibodies to aspirin: a case

report. Ann Allergy. 1989;62: 295–298.

22. Simon RA.

Prevention and treatment of reactions to NSAIDs. Clin Rev Allergy Immunol.

2003;24:189 –198.

Ann Allergy. 1989

Apr;62(4):295-8.

Angioedema and IgE antibodies to aspirin: a case report.

Blanca M, E, JJ, Miranda A, Terrados S, Vega JM, Suau R.

Internal Medicine Department, Haya Hospital, Malaga, Spain.

We present a case of a patient who developed two episodes of

angioedema after taking acetylsalicylic acid orally. Specific IgE antibodies to

acetylsalicylic human serum albumin (ASA-HSA) were found. A control group of 37

patients with aspirin intolerance was studied and evidence of specific IgE

antibodies was not found. The follow-up of this case shows that in a short

period of time the level of specific IgE antibody decreases to undetectable

levels similar to the negative control population.

-------------

- so, apparently, IgE antibodies specific to ASA-HSA apparently do

exist, but this is rare, or not easily detectable because even in this case,

the specific IgE return to zero after the event.

--------------

Clin Rev Allergy Immunol. 2003

Apr;24(2):189-98.

Prevention and treatment of reactions to NSAIDs.

Simon RA.

Divison of Allergy, Asthma, and Immunology, The Scripps Clinic and

Research Institute, La Jolla, CA 92037, USA. rsimon@...

Avoidance of ASA and other NSAIDs prevents the reactions and careful

attention to clinical history along with patient education are important.

However, blanket advice to avoid all NSAIDs is no longer reasonable. Except for

AERD and chronic urticaria, cross-reactivity with other NSAIDs does not occur.

A physician can definitively prove this by giving the patient another NSAID in

their office and observing no reaction. Furthermore, for patients with AERD and

chronic urticaria, they can be given the new selective COX-2 inhibitors

(rofecoxib and celecoxib) without any cross-reactivity. All AERD patients can

be desensitized to ASA and treated with ASA indefinitely. However, ASA

desensitization in chronic urticaria is not possible. Underlying mild and

moderate AERD responds well to topical and systemic corticosteroids and

leukotriene modifiers. However, the severe forms of the disease should be

desensitized to ASA and treated with this drug on a long term basis. In the

future, new drugs that prevent eosinophil activation and chemotaxis or enhance

eosinophil apoptosis are likely to be useful. Specific blockers of the second

cystLT receptor would also be useful. Ultimately as the genetics of these

heterogeneous disorders are unraveled, gene substitution therapy may be the

ultimate answer.

------------

and here I have not

read the entire article, but I am not convinced at all by some of the

across-the-board assertions in the abstract, notably that "All AERD

patients can be desensitized and treated with ASA indefinitely". The

abstract does not mention IgE, so I can't say what evidence RA Simon has to

present.

From the above, it

would seem that IgE-mediated ASA hypersensitivity is rare, and that it is

difficult to say whether the apparition of specific IgE antibodies against ASA

results from a condition distinct from the one resulting from AA metabolism, or

whether it is linked to it.

To add to this

possibility, some hypersensitivity specialists have now put forth the

hypothesis that NSAID hypersensitivity does come from AA metabolism, and is

explained by dose-dependance :

"The finding

that clinical hypersensitivity to NSAIDs is often accompanied by

dose-dependent in vitro basophil hypersensitivity is not revolutionary. It

corresponds rather well with the hypothesis that NSAID hypersensitivity

is not an immunological but a pharmacological phenomenon related to

the inhibitory effect of these drugs on prostaglandin synthesis [4]. The

fact that some controls that are clinically tolerant to NSAIDs show

positive BAT results and that some clinically hypersensitive patients show

negative BAT results does not invalidate the hypothesis. It is well

documented that the minimum NSAID dose needed to elicit clinical

symptoms can vary by a factor of as much as 100 (eg, 5-500 mg)

in hypersensitive patients."

in :

J Investig Allergol Clin Immunol. 2009;19(5):355-69.

Nonsteroidal anti-inflammatory drug hypersensitivity syndrome.

A multicenter study. I. Clinical findings and in vitro diagnosis.

De Weck AL, Sanz ML, Gamboa PM, Aberer W, Blanca M, Correia S, Erdman S, Jermann JM, Kanny G, Kowalski M, Mayorga L, Medrala W, Merk A, Sturm GJ, Sainte-Laudy

J, Schneider MS, Sczczeklik A, Weber JM, Wedi A.

Department of Allergology and Clinical Immunology, Clinica Universidad

de Navarra, Collaborative center of Pamplona, Spain.

---------

Personally, I do

believe like you that many groups are likely to overlap, and I also believe

that genetic polymorphisms and dose-dependance might explain the spectrum of

reactions to ASA.

The clinical

implications of this for us, who belong to the AERD subset of aspirin

intolerance, is that this results in impaired host defense of the airways and

facilitates both the development of allergies and colonization by pathogens

such s biofilms.

Let us also remember

that we may have ASA-independant conditions in addition !

-----------

Allerg Immunol

(Paris). 2001 Mar;33(3):120-6.

[Acetylsalicylic

acid: hypersensitivity, intolerance, or allergy?]

[Article in French]

Sainte-Laudy J.

Unité

d'immuno-allergologie, Laboratoire Pasteur-Cerba, 95066 Cergy-Pontoise.

After a century of

therapeutic use of acetyl salicylic acid (ASA), the different mechanisms

involved leading to the therapeutic activity and to the various clinical

reactions (even life threatening) observed in patients sensitive to ASA or in

general to the non steroidal anti-inflammatory drugs (NSAID's) are still to be

discovered or confirmed. During the last century a lot of scientific results

have been published in favour of a wide panel of mechanism including an humoral

(IgE and/or IgG) or a cellular (lymphocytes) immune reaction, inhibition of the

cyclooxygenases, a cellular activation (mast cells, basophils, eosinophils and

platelets), a competition at the serum albumin level and an activation of the

complement cascade. In general the same actors than in the anaphylactic

reaction are found (mediators, cellular activation and amplification systems).

It is clear today that these reactions for which an accurate diagnosis is

mandatory cannot be explained by a single mechanism, which is the case of a lot

of other allergens.

>> Pathogenesis,diagnosis, and treatment of aspirin intolerance,Jennek et al,Ann Allergy Asthma immunol,Vo 99,July2007,pgs13-21. > This summary discusses two groups of AI. One hypothesis proposes that AI results directly from an unspecific,non IgE-dependant degranulation of mast cells and eosinophils in an pseudoallergic reaction in which symtoms appear after the first intake of the drug (ASA or another NSAID).These reactions were associated with increased Cys-LTs and eosinophilic cationic protein( ie reactions related to COX-1 inhibition ) reflecting activation of eosinophils and an increase in prostaglandin D2 which mirrors mast cell activation.Studies showing increased histamine and trytase levels after taking asa in AI individuals without detection of asa specific IgE supports the pseudoallergic theory as a cause for AI in most cases.Desensitization for these individuals would seem a safer procedure. > However in another group of AI individuals exposure to an NSAID can result in anaphylaxis(IgE mediated reaction).Anaphylactoid reactions with acute urticaria and angioedema or even anaphylactic shock. Repeated exposure(desensitization) to an NSAID leads to saturation of anti-NSAID IgE antibody binding sites on mast cells and basophils.Desenitization in this group of AI individuals only under medical supervision where equipped to handle anaphylaxis.Cross reactivity is not as generallized as in the first group( ie antibody specfic) > Correct me if I am wrong but the urticaria can exist in both groups.Also it would make sense that these two groups might overlap to some extent.An interesting discussion would involve when an individual with AI develops the IgE specific reactions because this must be mostly where the desensitization risks lie. Wayne>

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...